UBS Group’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.36M Sell
154,184
-8,880
-5% -$78.2K ﹤0.01% 4119
2025
Q1
$1.22M Sell
163,064
-180,754
-53% -$1.35M ﹤0.01% 4045
2024
Q4
$2.87M Buy
343,818
+323,884
+1,625% +$2.7M ﹤0.01% 3429
2024
Q3
$138K Buy
19,934
+7,002
+54% +$48.6K ﹤0.01% 4944
2024
Q2
$63.4K Sell
12,932
-30,016
-70% -$147K ﹤0.01% 5359
2024
Q1
$249K Buy
42,948
+7,838
+22% +$45.5K ﹤0.01% 4563
2023
Q4
$230K Buy
35,110
+16,368
+87% +$107K ﹤0.01% 4525
2023
Q3
$90.3K Sell
18,742
-1,350
-7% -$6.51K ﹤0.01% 4778
2023
Q2
$102K Buy
20,092
+15,953
+385% +$81.4K ﹤0.01% 4942
2023
Q1
$22.8K Sell
4,139
-2,842
-41% -$15.6K ﹤0.01% 5891
2022
Q4
$32K Buy
6,981
+6,004
+615% +$27.6K ﹤0.01% 6005
2022
Q3
$6K Sell
977
-4,821
-83% -$29.6K ﹤0.01% 7975
2022
Q2
$26K Buy
+5,798
New +$26K ﹤0.01% 5540
2022
Q1
Sell
-10,499
Closed -$92K 9682
2021
Q4
$92K Buy
+10,499
New +$92K ﹤0.01% 5314
2021
Q2
Sell
-13,283
Closed -$122K 8639
2021
Q1
$122K Buy
+13,283
New +$122K ﹤0.01% 4830
2020
Q2
Sell
-1,739
Closed -$6K 7357
2020
Q1
$6K Buy
+1,739
New +$6K ﹤0.01% 6321
2019
Q4
Sell
-1
Closed 7221
2019
Q3
$0 Hold
1
﹤0.01% 7193
2019
Q2
$0 Sell
1
-46
-98% ﹤0.01% 7174
2019
Q1
$1K Sell
47
-134
-74% -$2.85K ﹤0.01% 6732
2018
Q4
$5K Buy
+181
New +$5K ﹤0.01% 6635
2018
Q3
Sell
-219
Closed -$23K 7204
2018
Q2
$23K Buy
219
+115
+111% +$12.1K ﹤0.01% 5693
2018
Q1
$14K Buy
104
+56
+117% +$7.54K ﹤0.01% 5791
2017
Q4
$3K Sell
48
-152
-76% -$9.5K ﹤0.01% 6570
2017
Q3
$12K Buy
200
+148
+285% +$8.88K ﹤0.01% 5885
2017
Q2
$3K Sell
52
-47
-47% -$2.71K ﹤0.01% 6354
2017
Q1
$8K Buy
+99
New +$8K ﹤0.01% 5836
2016
Q2
Sell
-1,699
Closed -$394K 6946
2016
Q1
$394K Buy
1,699
+1,609
+1,788% +$373K ﹤0.01% 3284
2015
Q4
$29K Buy
+90
New +$29K ﹤0.01% 5234
2015
Q3
Sell
-19
Closed -$6K 6968
2015
Q2
$6K Buy
+19
New +$6K ﹤0.01% 6228